PLA2G7 and Stroke: In a multicenter, randomized control clinical trial, Lp-PLA2 activity was not found to increase in patients who were without intracranial artery stenosis, which suggests a better response to dual antiplatelet therapy in patients with mild stroke or high-risk transient ischemic attack to prevent dual stroke and concurrent vascular events [42].